Warning: This is probably not for you.
Warning: This is probably not for you.
Mind Cure Health will be focusing its psychedelic drug R&D on psilocybin, ketamine and ibogaine. The Company will be pursuing both pain-based and mental health applications for psychedelics.
One of Bitcoin’s most prominent investors is making a new monster bet.
ATAI Life Science's IPO in 2021 is expected to be another big industry catalyst. But one company that might NOT benefit is Compass Pathways.
Roughly $500 million dollars has recently flooded into the coffers of psychedelic drug companies. That's enough capital to power a lot of growth.
A Psychedelic Drug Revolution is occurring -- to bring badly needed psychedelic medicines to a world suffering from a Mental Health Crisis.
ATAI Life Sciences is going public. MindMed Inc is hitting new highs. The two events ARE connected.
Mind Cure Health just cashed up. Mind Cure's share price has recently slid. Buying opportunity.
What's the best "investment advice" that any of us could receive in 2020? Invest in Small Business.
Will psychedelic drug therapies (simultaneously) save lives as they cure mental health disorders?
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now